MesoTRAP: a feasibility study that includes a pilot clinical trial comparing video-assisted thoracoscopic partial pleurectomy decortication with indwelling pleural catheter in patients with trapped lung due to malignant pleural mesothelioma designed to address recruitment and randomisation uncertainties and sample size requirements for a phase III trial

Claire Matthews, Carol Freeman, Linda D Sharples, Julia Fox-Rushby, Angela Tod, Nicholas A Maskell, John G Edwards, Aman S Coonar, Pasupathy Sivasothy, Victoria Hughes, Najib M Rahman, David A Waller, Robert Campbell Rintoul, Claire Matthews, Carol Freeman, Linda D Sharples, Julia Fox-Rushby, Angela Tod, Nicholas A Maskell, John G Edwards, Aman S Coonar, Pasupathy Sivasothy, Victoria Hughes, Najib M Rahman, David A Waller, Robert Campbell Rintoul

Abstract

Introduction: One of the most debilitating symptoms of malignant pleural mesothelioma (MPM) is dyspnoea caused by pleural effusion. MPM can be complicated by the presence of tumour on the visceral pleura preventing the lung from re-expanding, known as trapped lung (TL). There is currently no consensus on the best way to manage TL. One approach is insertion of an indwelling pleural catheter (IPC) under local anaesthesia. Another is video-assisted thoracoscopic partial pleurectomy/decortication (VAT-PD). Performed under general anaesthesia, VAT-PD permits surgical removal of the rind of tumour from the visceral pleura thereby allowing the lung to fully re-expand.

Methods and analysis: MesoTRAP is a feasibility study that includes a pilot multicentre, randomised controlled clinical trial comparing VAT-PD with IPC in patients with TL and pleural effusion due to MPM. The primary objective is to measure the SD of visual analogue scale scores for dyspnoea following randomisation and examine the patterns of change over time in each treatment group. Secondary objectives include documenting survival and adverse events, estimating the incidence and prevalence of TL in patients with MPM, examining completion of alternative forms of data capture for economic evaluation and determining the ability to randomise 38 patients in 18 months.

Ethics and dissemination: This study was approved by the East of England-Cambridge Central Research Ethics Committee and the Health Research Authority (reference number 16/EE/0370). We aim to publish the outputs of this work in international peer-reviewed journals compliant with an Open Access policy.

Trial registration: NCT03412357.

Keywords: asbestos induced lung disease; mesothelioma; pleural disease; thoracic surgery.

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Study flow chart. IPC, indwelling pleural catheter; MPM, malignant pleural mesothelioma; VAT-PD, video-assisted thoracoscopic partial pleurectomy decortication. MesoTRAP Investigators (6 August 2018).

References

    1. Current asbestos ban. 2018. Available from: [Accessed 16 Jul 2018].
    1. Odgerel CO, Takahashi K, Sorahan T, et al. . Estimation of the global burden of mesothelioma deaths from incomplete national mortality data. Occup Environ Med 2017;74:851–8. 10.1136/oemed-2017-104298
    1. Asbestos related disease. 2018. Available from: [Accessed 27 Mar 2018].
    1. Hodgson JT, McElvenny DM, Darnton AJ, et al. . The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050. Br J Cancer 2005;92:587–93. 10.1038/sj.bjc.6602307
    1. Beckett P, Edwards J, Fennell D, et al. . Demographics, management and survival of patients with malignant pleural mesothelioma in the National Lung Cancer Audit in England and Wales. Lung Cancer 2015;88:344–8. 10.1016/j.lungcan.2015.03.005
    1. Vogelzang NJ, Rusthoven JJ, Symanowski J, et al. . Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 2003;21:2636–44. 10.1200/JCO.2003.11.136
    1. Wahidi MM, Reddy C, Yarmus L, et al. . Randomized trial of pleural fluid drainage frequency in patients with malignant pleural effusions. the ASAP trial. Am J Respir Crit Care Med 2017;195:1050–7. 10.1164/rccm.201607-1404OC
    1. Bhatnagar R, Keenan EK, Morley AJ, et al. . Outpatient talc administration by indwelling pleural catheter for malignant effusion. N Engl J Med 2018;378:1313–22. 10.1056/NEJMoa1716883
    1. Fysh ETH, Tremblay A, Feller-Kopman D, et al. . Clinical outcomes of indwelling pleural catheter-related pleural infections: an international multicenter study. Chest 2013;144:1597–602. 10.1378/chest.12-3103
    1. Davies HE, Mishra EK, Kahan BC, et al. . Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial. JAMA 2012;307:2383–9. 10.1001/jama.2012.5535
    1. Rathinam S, Waller DA. Pleurectomy decortication in the treatment of the "trapped lung" in benign and malignant pleural effusions. Thorac Surg Clin 2013;23:51–61. 10.1016/j.thorsurg.2012.10.007
    1. Rintoul RC, Ritchie AJ, Edwards JG, et al. . Efficacy and cost of video-assisted thoracoscopic partial pleurectomy versus talc pleurodesis in patients with malignant pleural mesothelioma (MesoVATS): an open-label, randomised, controlled trial. Lancet 2014;384:1118–27. 10.1016/S0140-6736(14)60418-9
    1. Bazerbashi S, Villaquiran J, Awan MY, et al. . Ambulatory intercostal drainage for the management of malignant pleural effusion: a single center experience. Ann Surg Oncol 2009;16:3482–7. 10.1245/s10434-009-0691-2
    1. Qureshi RA, Collinson SL, Powell RJ, et al. . Management of malignant pleural effusion associated with trapped lung syndrome. Asian Cardiovasc Thorac Ann 2008;16:120–3. 10.1177/021849230801600208
    1. McBrearty C, Cooper D, Bourke SC, et al. . 47 Audit of medical thoracoscopy at North Tyneside general hospital. Lung Cancer 2012;75(S16):S16 10.1016/S0169-5002(12)70048-X
    1. Efthymiou CA, Masudi T, Thorpe JA, et al. . Malignant pleural effusion in the presence of trapped lung. Five-year experience of PleurX tunnelled catheters. Interact Cardiovasc Thorac Surg 2009;9:961–4. 10.1510/icvts.2009.211516
    1. Kulkarni V, Fernandez-Bussy S, Jantz MA. Medical thoracoscopy with simultaneous placement of a pleurx catheter for management of malignant pleural effusions. Chest 2009;136:85S 10.1378/chest.136.4_MeetingAbstracts.85S
    1. Chee A, Tremblay A. The use of tunneled pleural catheters in the treatment of pleural effusions. Curr Opin Pulm Med 2011;17:237–41. 10.1097/MCP.0b013e3283463dac
    1. Scherpereel A, Astoul P, Baas P, et al. . Guidelines of the European respiratory society and the European society of thoracic surgeons for the management of malignant pleural mesothelioma. Eur Respir J 2010;35:479–95. 10.1183/09031936.00063109
    1. Curran D, Sahmoud T, Therasse P, et al. . Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience. J Clin Oncol 1998;16:145–52. 10.1200/JCO.1998.16.1.145
    1. Browne RH. On the use of a pilot sample for sample size determination. Stat Med 1995;14:1933–40. 10.1002/sim.4780141709
    1. Teare MD, Dimairo M, Shephard N, et al. . Sample size requirements to estimate key design parameters from external pilot randomised controlled trials: a simulation study. Trials 2014;15:264 10.1186/1745-6215-15-264
    1. Ritchie J, Lewis J, McNaughton Nicholls C. Qualitative research practice: a guide for social science students and researchers. 2nd edn London: Sage Publishing, 2013.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner